Monoclonal antibody against both IL-17A and IL-17F and use of the same
US10858427B2 · kind B2 · utility
1Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2017 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Mar 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an anti-IL 17 A/F antibody that binds to both IL-17A and IL-17F and inhibits the activities of both 1L-17A and IL-17F. The antibody comprises heavy chain CDRs 1-3 represented by SEQ ID NOs: 1-3 respectively and light chain CDRs 1-3 represented by SEQ ID NOs:4-6 respectively. The use of the antibody in the manufacture of a medicament for treating diseases associated with IL-17A and/or IL-17F in a subject, and the pharmaceutical composition comprising the antibody are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.